|Articles|March 1, 2004

Pharmacy Times

  • Volume 0
  • 0

Ofloxacin Tablets

Teva Pharmaceuticals USA (North Wales, Pa)recently announced the introduction and availability ofOfloxacin Tablets. This product is AB-rated and is bioequivalentto Ortho-McNeil?s Floxin tablets. The productis prescribed to patients to reduce the development ofdrug-resistant bacteria and to maintain the effectivenessof this and other antibacterial drugs. Ofloxacin Tablets areindicated for the treatment of adults with mild-to-moderateinfections (unless otherwise indicated) caused bysusceptible strains of designated microorganisms. Theseinfections include chronic bronchitis, community-acquiredpneumonia, and acute pelvic inflammatory disease,among others. Ofloxacin Tablets 200, 300, and 400 mgare available in bottle sizes of 100. For more information,visit www.tevapharmusa.com.

Articles in this issue

over 21 years ago

New Technologies Top Survey

over 21 years ago

PDX Software Gets High Marks

over 21 years ago

Seal•ON

over 21 years ago

SaltAire Sinus Relief

over 21 years ago

Zim's Crack Creme Hand Sanitizer

over 21 years ago

CoroWise Plant Sterols

over 21 years ago

Culturelle

Newsletter

Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.


Latest CME